Narcotic Drugs Global Market Report 2026

Description

A narcotic drug is a type of medication that acts on the central nervous system to induce sleepiness, relieve pain, produce euphoria, and sometimes cause hallucinations. Narcotic drugs are usually derived from the opium poppy plant but can also be synthetically manufactured.

The main types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance obtained from the dried latex of immature seed capsules of the opium poppy. These drugs can originate from natural, semi-synthetic, or synthetic sources and are used for various indications such as pain management, cough, diarrhea, dysentery, asthma, and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized by various end users such as hospitals, homecare providers, specialty clinics, and others.

Tariffs have influenced the narcotic drugs market by increasing the cost of importing raw materials and active pharmaceutical ingredients (APIs), particularly in semi-synthetic and synthetic drug segments. This has affected manufacturing and supply chains across North America and Europe, where hospitals and specialty clinics are major consumers. While tariffs have temporarily raised production costs, they have also encouraged local sourcing, domestic production, and innovation in synthetic narcotic formulations, potentially strengthening regional supply resilience.

The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the narcotic drugs industry. This narcotic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The narcotic drugs market size has grown steadily in recent years. It will grow from $14.71 billion in 2025 to $15.32 billion in 2026 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing prevalence of chronic pain, widespread opium cultivation, rising incidence of cancer-related pain, traditional reliance on hospital pharmacies, high prevalence of cough and diarrhea conditions.

The narcotic drugs market size is expected to see strong growth in the next few years. It will grow to $18.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to growing demand for abuse-deterrent formulations, expansion of online pharmacy channels, advancements in synthetic narcotics production, rising focus on personalized pain management, increasing regulatory approvals for new narcotic drugs. Major trends in the forecast period include rise in prescription drug monitoring programs, growth of pain management therapies, increasing abuse-deterrent formulations, expansion of specialty pharmacies, development of synthetic narcotics.

The rising incidence of chronic diseases is expected to drive the growth of the narcotic drug market in the coming years. Chronic diseases are illnesses that last three months or more and can progressively worsen over time. Narcotic drugs are used to manage chronic conditions by alleviating pain associated with cancer, chronic pain syndrome, terminal illnesses, and severe arthritis. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, over half a million (549,000) additional individuals in England were identified at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a notable increase from 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the rising incidence of chronic diseases is driving growth in the narcotic drug market.

Major companies operating in the narcotic drug market are increasingly focusing on product development and innovation to provide reliable solutions to patients and strengthen their market position. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, launched OPVEE (nalmefene) nasal spray, an opioid overdose rescue medication for natural and synthetic opioids such as fentanyl. It is recommended for immediate treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 years and older, based on the presence of respiratory and central nervous system depression.

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. Through this acquisition, Indivior PLC aims to strengthen its addiction treatment and science portfolio, particularly with OPNT003, an investigational opioid overdose therapy designed to address the current surge of US opioid overdoses caused by potent synthetic opioids such as fentanyl. Opiant Pharmaceuticals Inc. is a US-based pharmaceutical company specializing in the development and manufacture of narcotic drugs.

Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals Plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Asia-Pacific was the largest region in the narcotic drugs market in 2025. The regions covered in the narcotic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the narcotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcotic Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The narcotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Drug: Opium; Heroin; Codeine; Oxycodone; Other Drugs
2) By Source: Natural; Semi-Synthetic; Synthetic
3) By Indication: Pain Management; Cough; Diarrhea; Dysentery; Other Indications
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Opium: Raw Opium; Opium Extracts; Opium Derivatives
2) By Heroin: Diacetylmorphine; Heroin Hydrochloride; Heroin Acetate
3) By Codeine: Codeine Phosphate; Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride; Oxycodone Acetaminophen; Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl; Morphine; Hydromorphone; Methadone; Buprenorphine
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; AbbVie Inc.; Novartis AG; AstraZeneca PLC; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Limited; Sun Pharmaceutical Industries Ltd.; Purdue Pharma LP; Hikma Pharmaceuticals Plc; Endo Pharmaceuticals Inc.; Amneal Pharmaceuticals LLC; Lupin Ltd.; Mallinckrodt Pharmaceuticals; Alvogen Inc.; Indivior Inc.; Impax Laboratories Inc.; Collegium Pharmaceutical Inc.; Lannett Co Inc.; Par Pharmaceutical Inc.; West-Ward Pharmaceuticals Corp.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MNDRU02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Narcotic Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Narcotic Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Narcotic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Narcotic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Rise In Prescription Drug Monitoring Programs
- 4.2.2 Growth Of Pain Management Therapies
- 4.2.3 Increasing Abuse-Deterrent Formulations
- 4.2.4 Expansion Of Specialty Pharmacies
- 4.2.5 Development Of Synthetic Narcotics

5. Narcotic Drugs Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Homecare
5.3 Specialty Clinics
5.4 Pain Management Centers
5.5 Rehabilitation Centers

6. Narcotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Narcotic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Narcotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Narcotic Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Narcotic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Narcotic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Narcotic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Narcotic Drugs Market Segmentation

9.1. Global Narcotic Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Opium, Heroin, Codeine, Oxycodone, Other Drugs
9.2. Global Narcotic Drugs Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Natural, Semi-Synthetic, Synthetic
9.3. Global Narcotic Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pain Management, Cough, Diarrhea, Dysentery, Other Indications
9.4. Global Narcotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
9.5. Global Narcotic Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Specialty Clinics, Other End Users
9.6. Global Narcotic Drugs Market, Sub-Segmentation Of Opium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Raw Opium, Opium Extracts, Opium Derivatives
9.7. Global Narcotic Drugs Market, Sub-Segmentation Of Heroin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diacetylmorphine, Heroin Hydrochloride, Heroin Acetate
9.8. Global Narcotic Drugs Market, Sub-Segmentation Of Codeine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Codeine Phosphate, Codeine Sulfate
9.9. Global Narcotic Drugs Market, Sub-Segmentation Of Oxycodone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oxycodone Hydrochloride, Oxycodone Acetaminophen, Controlled-Release Oxycodone
9.10. Global Narcotic Drugs Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fentanyl, Morphine, Hydromorphone, Methadone, Buprenorphine

10. Narcotic Drugs Market Regional And Country Analysis

10.1. Global Narcotic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Narcotic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Narcotic Drugs Market

11.1. Asia-Pacific Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Narcotic Drugs Market

12.1. China Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Narcotic Drugs Market

13.1. India Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Narcotic Drugs Market

14.1. Japan Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Narcotic Drugs Market

15.1. Australia Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Narcotic Drugs Market

16.1. Indonesia Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Narcotic Drugs Market

17.1. South Korea Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Narcotic Drugs Market

18.1. Taiwan Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Narcotic Drugs Market

19.1. South East Asia Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Narcotic Drugs Market

20.1. Western Europe Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Narcotic Drugs Market

21.1. UK Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Narcotic Drugs Market

22.1. Germany Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Narcotic Drugs Market

23.1. France Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Narcotic Drugs Market

24.1. Italy Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Narcotic Drugs Market

25.1. Spain Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Narcotic Drugs Market

26.1. Eastern Europe Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Narcotic Drugs Market

27.1. Russia Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Narcotic Drugs Market

28.1. North America Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Narcotic Drugs Market

29.1. USA Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Narcotic Drugs Market

30.1. Canada Narcotic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Narcotic Drugs Market

31.1. South America Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Narcotic Drugs Market

32.1. Brazil Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Narcotic Drugs Market

33.1. Middle East Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Narcotic Drugs Market

34.1. Africa Narcotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Narcotic Drugs Market, Segmentation By Drug, Segmentation By Source, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Narcotic Drugs Market Regulatory and Investment Landscape

36. Narcotic Drugs Market Competitive Landscape And Company Profiles

36.1. Narcotic Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Narcotic Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Narcotic Drugs Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Narcotic Drugs Market Other Major And Innovative Companies

Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals Plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc.

38. Global Narcotic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Narcotic Drugs Market

40. Narcotic Drugs Market High Potential Countries, Segments and Strategies

40.1 Narcotic Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Narcotic Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Narcotic Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer